Mrs. Zelna Booth

Zelna Booth is a South African researcher whose work centres on antimicrobial resistance, pharmacology, and pharmaceutical practice. Her scholarship bridges laboratory-based microbiological investigations with public health and healthcare systems research, reflecting a strong commitment to addressing pressing infectious disease challenges within the African context.

Her studies explore the interactions between African medicinal plants and conventional antimicrobials, highlighting both synergistic potential and risks of antagonism or toxicity. Through in vitro antimicrobial assays and toxicity screening, she contributes critical evidence on combination therapies and their implications for resistance development. Complementing this, her research on antibiotic utilisation in intensive care settings examines prescribing patterns during COVID-19, reinforcing the importance of stewardship and rational medicine use.

Booth has also engaged in advancing equity in pharmaceutical education through work aligned with international professional initiatives. Based on the currently available publications, her profile reflects an emerging researcher with interdisciplinary strengths spanning pharmacognosy, clinical pharmacy, antimicrobial stewardship, and health systems improvement.